Blu Pharmaceuticals Opens New Plant

US generic drug manufacturing and distribution company, Blu Pharmaceuticals, has opened a new production plant in Dorado, Puerto Rico. The firm is expected to invest US$60mn in the next three years at the US Food and Drug Administration (FDA)-approved facility. The facility will be known as Blu Caribe. BMI notes the importance of foreign investment in Puerto Rico as it struggles with high

To read the full article, please choose one of the following options: